XML 47 R5.htm IDEA: XBRL DOCUMENT v3.2.0.727
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Cash flows from operating activities:    
Net income (loss) $ 255,300 $ (152,796)
Adjustment to reconcile net income to cash provided by operating activities:    
Depreciation and amortization 942,000 1,073,427
Amortization of debt discount 70,391 60,306
Change in value of swap agreement 0 (39,017)
Stock based compensation 18,619 43,209
Provision for losses on accounts receivable 20,127 39,905
Provision for losses on inventories 162,933 10,629
Deferred income taxes (13,896) (324,509)
Change in assets and liabilities:    
Accounts receivable 1,869,983 (1,182,774)
Inventories (619,376) (1,187,929)
Prepaid expenses and other assets 417,673 (49,417)
Trade payables 876,183 2,655,129
Accrued liabilities (520,139) (935,661)
Net cash provided by operating activities 3,479,798 10,502
Cash used in investing activities - purchases of property, plant and equipment (194,264) (618,834)
Cash flows from financing activities:    
Change in checks written in excess of bank balance (865,442) 114,870
Net change in revolving line of credit (2,085,958) 26,868
Proceeds from issuance of long-term debt 4,473 55,960
Repayment of long-term debt (related parties $2,000 and $4,000) (262,800) (262,841)
Cash paid for deferred financing fees (5,244) 0
Purchase of treasury stock 0 (19,495)
Dividends paid (10,000) (16,000)
Proceeds from issuance of stock, net 0 300,000
Net cash (used in) provided by financing activities (3,224,971) 199,362
Effect of exchange rate changes on cash (6,856) 19,916
Net increase (decrease) in cash and cash equivalents 53,707 (389,054)
Cash and cash equivalents at beginning of period 150,332 666,616
Cash and cash equivalents at end of period 204,039 277,562
Supplemental disclosure of cash flow information:    
Cash payments for interest 630,202 571,491
Cash payments for taxes 0 55,466
Supplemental Disclosure of non-cash investing and financing activity Property, Plant & Equipment acquisitions funded by liabilities $ 29,226 $ 58,967